Company
Draig Therapeutics, Ltd
Draig Therapeutics is developing transformative, best-in-class neuropsychiatric therapies to restore the brain to a healthier state, enabling patients to live their best lives.
Also known as Draig Therapeutics, Draig Therapeutics Limited
- Business model
- B2B
- Founded
- 2024
- Legal name
- Draig Therapeutics Limited
- draigtherapeutics.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
Draig Therapeutics is developing transformative, best-in-class neuropsychiatric therapies to restore the brain to a healthier state, enabling patients to live their best lives. Anchored by decades of scientific learnings and drug development experience, Draig's highly specific neuromodulators are designed to enable safe, precise modulation of the major neurocircuits underlying neuropsychiatric disorders.
Funding snapshot
- Total raised
- $205MSum of rounds, as of 2026-09-17Source (opens in a new tab)
- Latest round
- Series B, $65M2026-07
Funding rounds
- Series B
- $65M2026-07, Company stated
- Round, 2025
- $140M2025-06, Company stated
Products
- Web
- DT-101
- Web
- GABA A receptor modulators
Loading relationship preview